UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$350M |
| 2 |
Cisco
CSCO
|
+$315M |
| 3 |
Coca-Cola
KO
|
+$282M |
| 4 |
Estee Lauder
EL
|
+$281M |
| 5 |
TUYA
Tuya Inc
TUYA
|
+$226M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$3.36B |
| 2 |
Alibaba
BABA
|
+$1.92B |
| 3 |
TAL Education Group
TAL
|
+$1.08B |
| 4 |
Procter & Gamble
PG
|
+$638M |
| 5 |
Lockheed Martin
LMT
|
+$424M |
Sector Composition
| 1 | Technology | 25.73% |
| 2 | Healthcare | 12.81% |
| 3 | Financials | 12.79% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Communication Services | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRTV
2301
DELISTED
VERITIV CORPORATION
VRTV
| $764K | ﹤0.01% |
+12,440
| New | +$764K |
|
2302
Cass Information Systems
CASS
$563M
| $764K | ﹤0.01% |
18,740
+841
| +5% | +$34.3K |
|
|
HEXO
2303
DELISTED
HEXO Corp. Common Shares
HEXO
| $762K | ﹤0.01% |
+9,357
| New | +$762K |
|
2304
Banc of California
BANC
$2.65B
| $758K | ﹤0.01% |
43,232
+9,122
| +27% | +$160K |
|
2305
Agilysys
AGYS
$3.03B
| $757K | ﹤0.01% |
13,318
+1,506
| +13% | +$85.6K |
|
|
KBAL
2306
DELISTED
Kimball International
KBAL
| $756K | ﹤0.01% |
57,522
+1,947
| +4% | +$25.6K |
|
2307
Standard BioTools
LAB
$489M
| $756K | ﹤0.01% |
122,719
+15,819
| +15% | +$97.4K |
|
2308
Tucows
TCX
$196M
| $755K | ﹤0.01% |
9,400
+646
| +7% | +$51.9K |
|
2309
Akebia Therapeutics
AKBA
$795M
| $753K | ﹤0.01% |
198,740
+105,322
| +113% | +$399K |
|
2310
HealthStream
HSTM
$850M
| $750K | ﹤0.01% |
26,858
+1,887
| +8% | +$52.7K |
|
2311
Trustco Bank Corp NY
TRST
$738M
| $750K | ﹤0.01% |
21,809
+1,196
| +6% | +$41.1K |
|
2312
Donnelley Financial Solutions
DFIN
$1.53B
| $749K | ﹤0.01% |
+22,702
| New | +$749K |
|
2313
Energy Recovery
ERII
$765M
| $747K | ﹤0.01% |
32,770
-3,600
| -10% | -$82K |
|
2314
Ranpak Holdings
PACK
$408M
| $743K | ﹤0.01% |
29,671
+5,371
| +22% | +$134K |
|
|
GOOD
2315
Gladstone Commercial Corp
GOOD
$605M
| $741K | ﹤0.01% |
32,845
+3,407
| +12% | +$76.9K |
|
|
CLVS
2316
DELISTED
Clovis Oncology, Inc.
CLVS
| $739K | ﹤0.01% |
127,366
+50,162
| +65% | +$291K |
|
|
MYOV
2317
DELISTED
Myovant Sciences Ltd.
MYOV
| $739K | ﹤0.01% |
32,442
+2,812
| +9% | +$64K |
|
|
CMRX
2318
DELISTED
Chimerix, Inc.
CMRX
| $738K | ﹤0.01% |
+92,294
| New | +$738K |
|
2319
Ambac
AMBC
$424M
| $737K | ﹤0.01% |
47,069
+3,469
| +8% | +$54.3K |
|
2320
Central Pacific Financial
CPF
$829M
| $737K | ﹤0.01% |
28,273
+2,580
| +10% | +$67.2K |
|
2321
Alaunos Therapeutics
TCRT
$5.07M
| $734K | ﹤0.01% |
1,853
+334
| +22% | +$132K |
|
2322
Syndax Pharmaceuticals
SNDX
$1.37B
| $733K | ﹤0.01% |
42,672
+4,285
| +11% | +$73.6K |
|
2323
Tactile Systems Technology
TCMD
$305M
| $731K | ﹤0.01% |
14,067
+1,304
| +10% | +$67.8K |
|
2324
A10 Networks
ATEN
$1.26B
| $730K | ﹤0.01% |
64,796
+2,179
| +3% | +$24.5K |
|
2325
Civitas Resources
CIVI
$3.01B
| $729K | ﹤0.01% |
15,480
+1,633
| +12% | +$76.9K |
|